Hostname: page-component-8448b6f56d-c47g7 Total loading time: 0 Render date: 2024-04-19T11:48:59.961Z Has data issue: false hasContentIssue false

Bovine leukaemia virus DNA in fresh milk and raw beef for human consumption

Published online by Cambridge University Press:  28 September 2017

N. N. OLAYA-GALÁN*
Affiliation:
PhD Programme in Biomedical and Biological Sciences, Universidad del Rosario, Bogotá, Colombia Grupo de Enfermedades Infecciosas, Laboratorio de Virología, Departamento de Microbiología, Pontificia Universidad Javeriana, Bogotá, Colombia
A. P. CORREDOR-FIGUEROA
Affiliation:
Grupo de Enfermedades Infecciosas, Laboratorio de Virología, Departamento de Microbiología, Pontificia Universidad Javeriana, Bogotá, Colombia
T. C. GUZMÁN-GARZÓN
Affiliation:
Grupo de Enfermedades Infecciosas, Laboratorio de Virología, Departamento de Microbiología, Pontificia Universidad Javeriana, Bogotá, Colombia
K. S. RÍOS-HERNANDEZ
Affiliation:
Grupo de Enfermedades Infecciosas, Laboratorio de Virología, Departamento de Microbiología, Pontificia Universidad Javeriana, Bogotá, Colombia
S. P. SALAS-CÁRDENAS
Affiliation:
Grupo de Enfermedades Infecciosas, Laboratorio de Virología, Departamento de Microbiología, Pontificia Universidad Javeriana, Bogotá, Colombia
M. A. PATARROYO
Affiliation:
Molecular Biology and Immunology Department, Fundación Instituto de Inmunología de Colombia (FIDIC), Bogotá, Colombia Basic Sciences Department, School of Medicine and Health Sciences, Universidad del Rosario, Bogotá, Colombia
M. F. GUTIERREZ
Affiliation:
Grupo de Enfermedades Infecciosas, Laboratorio de Virología, Departamento de Microbiología, Pontificia Universidad Javeriana, Bogotá, Colombia
*
*Author for correspondence: N. N. Olaya-Galán, Grupo de Enfermedades Infecciosas, Laboratorio de Virología, Departamento de Microbiología, Pontificia Universidad Javeriana, Carrera 7 No. 40 – 62, Building 50 Lab. 123, Bogotá, Colombia. (E-mail: nuryolaya@gmail.com)
Rights & Permissions [Opens in a new window]

Summary

Bovine leukaemia virus (BLV) is the causative agent of enzootic bovine leucosis, which has been reported worldwide. BLV has been found recently in human tissue and it could have a significant impact on human health. A possible hypothesis regarding viral entry to humans is through the consumption of infected foodstuffs. This study was aimed at detecting the presence of BLV DNA in raw beef and fresh milk for human consumption. Nested PCR directed at the BLV gag gene (272 bp) was used as a diagnostic test. PCR products were confirmed by Sanger sequencing. Forty-nine per cent of the samples proved positive for the presence of proviral DNA. This is the first study highlighting the presence of the BLV gag gene in meat products for human consumption and confirms the presence of the viral DNA in raw milk, as in previous reports. The presence of viral DNA in food products could suggest that viral particles may also be found. Further studies are needed to confirm the presence of infected viral particles, even though the present findings could represent a first approach to BLV transmission to humans through foodstuff consumption.

Type
Original Papers
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
Copyright © Cambridge University Press 2017

INTRODUCTION

Bovine leukaemia virus (BLV) belongs to the genus Deltaretrovirus, family Retroviridae, subfamily Oncovirinae. This is an oncogenic virus that was first isolated in 1969 and is the aetiological agent of enzootic bovine leucosis (EBL), one of the most frequently occurring neoplastic diseases in cattle [Reference Barez1]; about a third of BLV-infected cows develop persistent lymphocytosis, 1–5% of them developing the late stage of the disease that is associated with B-cell neoplasm [Reference Hemmatzadeh2]. This retrovirus is closely related to the types of human lymphotropic T-cell leukaemia virus (HTLV-1 and -2) [Reference Yuan3]. BLV integrates its genome in target bovine cells, so that all infected animals are persistently infected and become carriers of the virus during the course of their lives, thereby having a negative impact on the animals’ immune system and, consequently, induces losses in milk production, poorer yield regarding weight and induced abortions in the animals [Reference Barez1, Reference Úsuga-Monroy, Echeverri and López-Herrera4, Reference Acaite5].

A few studies have revealed the presence of DNA and proteins of BLV in human breast tissue samples, proposing that these findings could be considered as a hazardous factor for breast cancer development [Reference Buehring6Reference Mesa9]; albeit some different investigations have not found evidence of the virus in people [Reference Zhang10, Reference Gillet and Willems11], there is proof that a bovine virus is found in human beings, perhaps related to a zoonosis infection. However, it is still not known how BLV is transmitted to humans. Transmission in cattle could be mediated by horizontal or vertical transmission. Vertical transmission includes perinatal transmission through blood or transplacental passage and post-natal infection routes through colostrum and milk consumption [Reference Lassauzet12, Reference Mekata13]. Horizontal transmission could occur by direct contact between infected and non-infected animals, as well as veterinary practices due to using contaminated instruments on many animals without sterilising them between procedures and animals, including tattooing cattle, vaccination and rectal palpations [Reference Kobayashi14]. Conversely, it has been suggested that humans might become infected by consuming foodstuffs from infected animals, through the direct contact involved in livestock practices or vaccines produced with contaminated cattle sera [Reference Buehring7, Reference Buehring, Philpott and Choi15]. Although the transmission route has not yet been established, it could be implicated in as-yet-unknown human health issues such as the emergence of new diseases, taking into account that BLV is described as an oncogenic virus.

Food for human consumption has been proposed as a potential source of pathogen transmission. Several viral infections are related to foodborne diseases; enteric viruses, such as rotaviruses and noroviruses, are amongst the viral agents most frequently transmitted by foodstuffs; these agents are transmitted as free viral particles through faecal contamination of foodstuffs for direct consumption, such as fruit and vegetables and (in some exceptions) meat products [Reference Aw, Wengert and Rose16, Reference Rodríguez-Lázaro17]. Some other viral infections require the presence of infected cells to transmit the agent to other hosts; this is the case of hepatitis A virus and hepatitis E virus (HEV) that have been found in meat products, such as sausages, liver and pork [Reference Rivero-Juarez18Reference Szabo21].

There are other diseases that are, in principle, associated with foodstuff consumption but where the causative agent remains unknown [Reference Scallan22]; in spite of most of them being associated with gastrointestinal diseases, there could be other types of pathogens in foodstuffs that are still unknown. This could thus be happening with BLV, involving potential risk for human health. Studies focused on food safety for improving the quality of products prepared for human consumption are needed as foodstuffs could transmit unknown pathogens. This study was thus aimed at evaluating the BLV DNA detection in raw meat and fresh milk (i.e. fresh from milking) for human consumption as a first step in estimating the potential of foodstuffs regarding BLV transmission to humans.

METHODS

Sample collection

Convenience sampling was used for obtaining both milk and meat samples, 100 samples were obtained. Fifty beef samples weighing around 15 g each were obtained from butchers in Bogotá whilst the 50 samples of milk were obtained from farms specialising in dairy production located in different parts of Colombia. The milk was collected directly from milking (i.e. before being sent for industrial treatment). The samples were transported to the Virology Laboratory at the Javeriana University in Bogotá where meat samples were stored at −20 °C until being processed, whilst milk samples were processed immediately.

Sample preparation and nucleic acid extraction

Roche High Pure PCR Template Preparation Kit was used for extracting total nucleic acids from milk and meat, following the manufacturer's indications; some modifications were made for solid tissue and liquid samples. Regarding meat, an initial 10–20 mg of rump cut (muscle) was lysed with proteinase K and the tissue lysis buffer supplied in the DNA extraction kit. Extraction from milk samples first involved cell concentration from an initial 5 ml milk volume through sequential centrifugations at 16 000  g for 20 min for each cycle (four cycles in total); the pellet so obtained was used for DNA extraction, following the manufacturer's instructions. NanoDrop (Thermo) was used for quantifying the extracted DNA to verify its concentration and purity. The DNA was then frozen (−20 °C) and stored until further use.

PCR amplification: multiplex and nested PCR

The bovine GAPDH constitutive gene was used as PCR internal control, which was amplified in a multiplex PCR together with the virus’ gag gene encoding its capsid proteins. PCR tests were done using Roche PCR master mix with specific primers (0·8 pmol/μl) for the aforementioned genes. Both bovine GAPDH and gag primers were previously reported by Buehring et al. [Reference Buehring6]. An 857 bp fragment was amplified for the bovine GAPDH gene and a 385 bp fragment for gag. Multiplex PCR conditions included an initial denaturing step at 94 °C for 5 min, followed by 35 cycles of denaturing at 94 °C for 30 s, an annealing step at 59·3 °C for 60 s and a 90 s extension at 72 °C. A final extension step was performed at 72 °C for 10 min.

PCR sensitivity was increased by nested PCR for samples where the viral gene was not amplified in multiplex PCR. The first PCR's products were used as templates for the nested PCR. The amplification target was an internal gag fragment (nt 1097–1369), resulting in a 272 bp fragment (also reported by Buehring et al.) [Reference Buehring6]. Reaction conditions were the same as those described for multiplex PCR. Annealing temperature was 56 °C with 30 s extension time.

The results for both multiplex and nested PCR were visualised on 1·5% agarose gels prepared in 1× TAE (Biorad) dyed with 1× HydraGreen fluorescent intercalating dye (ACTGene). DNA extracted from a blood sample of an infected animal was used as positive control for BLV and RNase- and DNase-free water as negative amplification control.

Sequencing

Virus-positive PCR products were purified with PCR product purification kit (Roche High Pure), following the manufacturer's instructions, and then sent to Macrogen Inc. (Seoul, Korea), for Sanger sequencing. The primers (both sense and anti-sense) used for sequencing were the same as those for the nested PCR. BioEdit Sequence Alignment Editor (version 7·2·5) was used for editing and analysing the sequences. Consensus sequences were obtained for each positive sample; the online BLASTn tool was used for verifying the identity of the sequences so obtained.

RESULTS AND DISCUSSION

BLV has been known and studied as an infectious agent in cattle; however, there are reports of this virus in humans [Reference Buehring6, Reference Buehring7, Reference Mesa9] even though the mechanism by which the virus has reached such host has still not been clarified. Buehring et al. [Reference Buehring, Philpott and Choi15, Reference Buehring23] highlighted three main hypotheses for the viral entry to humans. The first considers direct contact with infected animals; however, such hypothesis would necessarily involve viral presence in limited populations (i.e. veterinarians, livestock handlers and/or farmers). Nevertheless, available evidence has revealed that the virus has been found in people who do not necessarily come into direct contact with animals [Reference Buehring6, Reference Buehring7, Reference Mesa9]. The second hypothesis concerns possible BLV transmission through vaccine production processes involving the use of BLV-contaminated foetal bovine sera, even though no experimental evidence has been published regarding this issue. The third hypothesis proposes that the virus might infect humans through the consumption of bovine-derived products from BLV-infected cattle [Reference Zhang10, Reference Buehring23], leading to the idea of evaluating meat and milk products for human consumption as a possible pathway for viral entry.

Nucleic acids were obtained from fresh milk and raw beef samples (muscle tissues) in the present study in the search for BLV proviral DNA. Internal control (bovine GAPDH) was observed in the multiplex PCR (Fig. 1a ). A proviral gag segment was found in 24 out of the 50 milk samples and in 25 of the meat samples. These results represent 49% of all samples analysed. Most of them were detected by nested PCR, suggesting that the viral load in the samples was considerably low. Figure one shows a representative agarose gel of the results obtained by multiplex PCR (a) where an 857 bp fragment from bovine GAPDH was observed, as well as the external gag fragment in positive control (385 bp); nested PCR (b) from the products obtained in the first PCR with a 272 bp fragment was observed in positive control and the samples analysed here (Figs. 1a and b ).

Fig. 1. Representative agarose gel (1·5%) of field samples. (a) Multiplex PCR. (b) Nested PCR. Lane 1 – 100 bp ladder (Invitrogen); lane 2 – positive control; lane 3 – negative control; lane 4–8: beef samples; lane 9–13: milk samples.

After sequencing PCR products, gag gene identity was verified using BLAST (NCBI) with previously reported BLV sequences. The results gave 97–99% identity compared to reference sequences. Such results confirmed that the amplified products obtained from meat and milk samples came from the BLV gag segment.

BLV prevalence in Colombia has been recorded as 67·7% on livestock farms throughout the country and in 43% of the bovine population, thereby affecting (health-wise and economically) livestock breeding for milk production and meat for human consumption [Reference Ortega24]. Understanding the evolution of the disease in cattle (most infected animals going unnoticed due to low symptomatology) [Reference Aida25] and considering its high prevalence in Colombia highlights the fact that infected animals that have never been detected could be sold for commercialisation, and thus cattle-derived infected products could be distributed in different industries without any government control regarding the presence of the virus. This would favour the disease's dissemination in spite of the fact that EBL was recently established and was considered a disease requiring mandatory notification by the Colombian Agricultural and Livestock Institute [26].

Detection of BLV DNA in cattle-derived foodstuffs (as shown by this study's findings) could serve as a marker, which could suggest a zoonosis (i.e. indicating viral particle transmission by these products). It is worth stressing that cases of zoonosis are considered one of the most important problems regarding infectious disease epidemiology and public health worldwide [Reference Hugh-Jones, Hubbert and Hacstad27]. Taking the WHO's definition of zoonosis, ‘Any disease or infection that is naturally transmissible from vertebrate animals to humans, including all types of pathogenic agents’, [28] as well as viral transmission mechanisms, action directed towards avoiding viral dissemination in cattle might prevent the introduction of the pathogen into the human population, even though BLV has not yet been conclusively proven to be a cause of human disease [Reference Buehring6, Reference Gillet and Willems11, Reference Sinha29].

Foodborne diseases are related with ingesting contaminated foodstuffs with microorganisms, which sometimes could come from an animal origin [Reference Greig and Ravel30]. Two vehicles have been proposed for viral transmission through foodstuff consumption. Free viral particles in foodstuffs has been related to an exogenous contamination source (i.e. faecal contamination), involving direct consumption of fresh products, such as fruit and vegetables [Reference Aw, Wengert and Rose16]. The other possibility concerns the transmission of viruses through animal-derived products infected with the virus. In this case, animal cells would become carriers of pathogenous agents, introducing them into human beings through consumption of meat from infected animals, trespassing even free viral particles, infected cells or proviral DNA [Reference Hugh-Jones, Hubbert and Hagstad31]. Reports regarding HEV entry to humans have increased due to products from pigs infected by the virus being consumed, i.e. sausages, liver and poorly cooked pork [Reference Rivero-Juarez18, Reference Di Bartolo19, Reference Szabo21, Reference Hartl, Wehmeyer and Pischke32]. This situation has led to acute hepatitis outbreaks where a hitherto disregarded zoonosis has been clearly defined. This study's findings have suggested that a similar situation could be occurring with BLV, giving rise to possible explanations for diseases whose causes have previously been undefined.

The pertinent literature has reported viral particles and viral DNA in cows’ milk or colostrum that could be considered a risk factor for transmission to calves [Reference Yamada33Reference Gutiérrez36]. Viral DNA was also detected in fresh milk in the present study, thereby agreeing with previous reports, despite not having been described as a risk factor for humans. Bearing this in mind, some other retroviruses could be transmitted by their respective hosts consuming milk, i.e. HTLV, MMTV (mammary murine tumor virus) and also HIV in particular situations [Reference Southern37Reference Lawson39].

Consuming raw milk could be a viable transmission pathway, mostly in developing countries having high raw milk consumption in rural populations. Previous studies have established that industrialisation of milk and pasteurisation processes leads to inactivating viral particles [Reference Baumgartener, Olson and Onuma40Reference Rubino and Donham42]; avoiding raw milk consumption would thus be an essential prevention strategy, even if it remains unknown whether BLV can also reach humans by this means.

It is worth highlighting that even though the study's objective was not to determine the presence of complete and infectious viral particles in the samples analysed, the gene fragments found here suggested the virus could be found, since comparing the sequences obtained here with previously reported ones gave 97–99% identity (i.e. dealing with BLV). Further studies should be aimed at establishing whether consuming the aforementioned foodstuffs transmits infective viral particles, which can then complete their biological cycle in humans. It could be of great interest to evaluate viral presence after cooking meat as this could inactivate viral particles and to ascertain whether other mechanisms could be participating in viral transmission [Reference Baumgartener, Olson and Onuma40].

Moreover, this is the first experimental approach reporting the BLV gag gene segment being detected in beef products for human consumption. Questions concerning viral transmission through consuming infected meat have been raised since the reports by Buehring et al. [Reference Buehring, Philpott and Choi15]. However, only empirical approaches and inferences about this transmission pathway have been proposed, regarding slaughterhouse practices involving carcinogenic cattle tissue where not only these tissues are distributed to humans, but have been disposed of for dog and cat food products [43]. The data reported here are important for foodborne infections and public health. Prevention policy, which proposes the early detection of pathogenous agents with a possibility to reach humans, depends on the risks for the target population, by controlling the main sources of dissemination [Reference Kelly44].

The presence of the BLV DNA in bovine-derived products could be interpreted as a step forward in identifying previously unknown foodborne diseases. Our results suggested that BLV could be considered a potential zoonotic agent, even though non-infectious particles were reported in this study. Evidence of an oncogenic virus’ DNA in milk and meat products highlights such foodstuffs as being a potential source of viral transmission to humans and could be the outcome of currently unknown diseases. Such viruses’ alternative transmission routes should be studied (i.e. human-to-human transmission). Prevention and control strategies should be enforced to decrease viral prevalence and transmission in cattle and ensure that infected foodstuffs do not become distributed to markets; such alternatives aimed at eradicating the disease have been achieved in some European countries, New Zealand and Australia [Reference Acaite5, Reference Nuotio45].

ACKNOWLEDGEMENTS

The authors would like to thank Jason Garry for translating this manuscript and the Vecol Institute for helping with sampling. This research was performed as part of a current project financed by Colciencias, Colombia, as part of call 657/2014 for projects.

DECLARATION OF INTEREST

None.

Footnotes

These authors contributed equally to this work.

References

REFERENCES

1. Barez, P-Y, et al. Recent advances in BLV research. Viruses 2015; 7: 60806088. doi:10.3390/v7112929.CrossRefGoogle ScholarPubMed
2. Hemmatzadeh, F, et al. Interaction between bovine leukemia virus (BLV) infection and age on telomerase misregulation. Veterinary Research Communications 2015; 39: 97103.Google Scholar
3. Yuan, Y, et al. Detection of the BLV provirus from nasal secretion and saliva samples using BLV-CoCoMo-qPCR-2: comparison with blood samples from the same cattle. Virus Research 2015; 210: 248254.Google Scholar
4. Úsuga-Monroy, C, Echeverri, J, López-Herrera, H. Diagnóstico molecular del virus de leucosis bovina en una población de vacas Holstein, Colombia. Archivos de Zootecnia 2015; 64: 383388.CrossRefGoogle Scholar
5. Acaite, J, et al. The eradication experience of enzootic bovine leukosis from Lithuania. Preventive Veterinary Medicine 2007; 82: 8389.Google Scholar
6. Buehring, GC, et al. Bovine leukemia virus DNA in human breast tissue. Emerging Infectious Diseases 2014; 20: 772782.Google Scholar
7. Buehring, GC, et al. Exposure to bovine leukemia virus is associated with breast cancer: a case-control study. PLoS ONE 2015; 10: e0134304.Google Scholar
8. Ochoa Cruz, A, Uribe, A, Gutiérrez, M. Estudio del potencial zoonótico del Virus de la Leucosis Bovina y su presencia en casos de cáncer de seno. Universitas Scientiarum. Bogota, Colombia: Pontificia Universidad Javeriana, 2006, pp. 3140.Google Scholar
9. Mesa, G, et al. Bovine leukemia virus gene segment detected in human breast tissue. Open Journal of Medical Microbiology 2013; 3: 8490.Google Scholar
10. Zhang, R, et al. Lack of association between bovine leukemia virus and breast cancer in Chinese patients. Breast Cancer Research 2016; 18: 101.CrossRefGoogle ScholarPubMed
11. Gillet, NA, Willems, L. Whole genome sequencing of 51 breast cancers reveals that tumors are devoid of bovine leukemia virus DNA. Retrovirology 2016; 13: 75.Google Scholar
12. Lassauzet, ML, et al. Factors associated with in utero or periparturient transmission of bovine leukemia virus in calves on a California dairy. Canadian Journal of Veterinary Research 1991; 55: 264268.Google Scholar
13. Mekata, H, et al. Horizontal transmission and phylogenetic analysis of bovine leukemia virus in two districts of Miyazaki, Japan. The Journal of Veterinary Medical Science 2015; 77: 11151120.Google Scholar
14. Kobayashi, S, et al. Analysis of risk factors associated with bovine leukemia virus seropositivity within dairy and beef breeding farms in Japan: a nationwide survey. Research in Veterinary Science 2014; 96: 4753.Google Scholar
15. Buehring, GC, Philpott, SM, Choi, KY. Humans have antibodies reactive with bovine leukemia virus. AIDS Research and Human Retroviruses 2003; 19: 11051113.Google Scholar
16. Aw, TG, Wengert, S, Rose, JB. Metagenomic analysis of viruses associated with field-grown and retail lettuce identifies human and animal viruses. International Journal of Food Microbiology 2016; 223: 5056.CrossRefGoogle ScholarPubMed
17. Rodríguez-Lázaro, D, et al. Presence of pathogenic enteric viruses in illegally imported meat and meat products to EU by international air travelers. International Journal of Food Microbiology 2015; 209: 3943.Google Scholar
18. Rivero-Juarez, A, et al. Familial hepatitis E outbreak linked to wild boar meat consumption. Zoonoses and Public Health 2017; 64: 15.Google Scholar
19. Di Bartolo, I, et al. Detection of hepatitis E virus in pork liver sausages. International Journal of Food Microbiology 2015; 193: 2933.Google Scholar
20. Fusco, G, et al. Prevalence of foodborne viruses in mussels in Southern Italy. Food and Environmental Virology 2017; 9: 187194.CrossRefGoogle ScholarPubMed
21. Szabo, K, et al. Detection of hepatitis E virus RNA in raw sausages and liver sausages from retail in Germany using an optimized method. International Journal of Food Microbiology 2015; 215: 149156.CrossRefGoogle ScholarPubMed
22. Scallan, E, et al. Foodborne illness acquired in the United States – unspecified agents. Emerging Infectious Diseases 2011; 17: 1622.Google Scholar
23. Buehring, GC. Response to ‘Lack of association between bovine leukemia virus and breast cancer in Chinese patients’. Breast Cancer Research 2017; 19. doi:10.1186/s13058-017-0808-7.Google Scholar
24. Ortega, DO, et al. Seroprevalence and risk factors associated with bovine leukemia virus in Colombia. Journal of Veterinary Medicine and Animal Health 2016; 8: 3543.Google Scholar
25. Aida, Y, et al. Mechanisms of pathogenesis induced by bovine leukemia virus as a model for human T-cell leukemia virus. Frontiers in Microbiology 2013; 4: 111.Google Scholar
26. Instituto Colombiano Agropecuario. Resolucion 3714- ‘Por la cual se establecen las enfermedades de declaración obligatoria en Colombia’. Bogotá, Colombia: Ministerio de Agricultura, 2015.Google Scholar
27. Hugh-Jones, ME, Hubbert, WT, Hacstad, HV. Section I: Introduction to the zoonoses. ZOONOSES: Recognition, Control, and Prevention. Iowa: Iowa State Press, 1995, pp. 737.Google Scholar
28. World Health organization – WHO. Zoonoses and the Human-Animal-Ecosystems Interface. WHO, 2013 (http://www.who.int/zoonoses/en/). Accessed 12 January 2017.Google Scholar
29. Sinha, G. Bovine leukemia virus possibly linked to breast cancer. Journal of the National Cancer Institute 2016; 108: djw020.CrossRefGoogle ScholarPubMed
30. Greig, JD, Ravel, A. Analysis of foodborne outbreak data reported internationally for source attribution. International Journal of Food Microbiology 2009; 130: 7787.Google Scholar
31. Hugh-Jones, ME, Hubbert, WT, Hagstad, HV. Principles of Zoonoses Control and Prevention. Zoonoses. Iowa, USA: Iowa State Press, 2000, pp. 79120.Google Scholar
32. Hartl, J, Wehmeyer, MH, Pischke, S. Acute hepatitis E: two sides of the same coin. Viruses 2016; 8: 299. doi:10.3390/v8110299.Google Scholar
33. Yamada, T, et al. Cell infectivity in relation to bovine leukemia virus gp51 and p24 in bovine milk exosomes. PLoS ONE 2013; 8: e77359.CrossRefGoogle ScholarPubMed
34. Meas, S, et al. Vertical transmission of bovine leukemia virus and bovine immunodeficiency virus in dairy cattle herds. Veterinary Microbiology 2002; 84: 275282.CrossRefGoogle ScholarPubMed
35. Kobayashi, S, et al. Risk factors associated with within-herd transmission of bovine leukemia virus on dairy farms in Japan. BMC Veterinary Research 2010; 6: 1.CrossRefGoogle ScholarPubMed
36. Gutiérrez, G, et al. Characterization of colostrum from dams of BLV endemic dairy herds. Veterinary Microbiology 2015; 177: 366369.Google Scholar
37. Southern, SO, et al. Persistent HTLV-I infection of breast luminal epithelial cells: a role in HTLV transmission? Virology 1998; 241: 200214.Google Scholar
38. Prameela, KK. HIV transmission through breastmilk: the science behind the understanding of current trends and future research. The Medical Journal of Malaysia 2012; 67: 644651.Google Scholar
39. Lawson, JS, et al. Breastfeeding, breast milk and viruses. BMC Women's Health 2007; 7: 17.Google Scholar
40. Baumgartener, L, Olson, C, Onuma, M. Effect of pasteurization and heat treatment on bovine leukemia virus. Journal of the American Veterinary Medical Association 1976; 169: 11891191.Google Scholar
41. Chung, YS, et al. The effect of pasteurisation on bovine leucosis virus-infected milk bovine leucosis virus. Australian Veterinary Journal 1986; 63: 379380.CrossRefGoogle ScholarPubMed
42. Rubino, MJ, Donham, KJ. Inactivation of bovine leukemia virus-infected lymphocytes in milk. American Journal of Veterinary Research 1984; 45: 15531556.Google Scholar
43. emilyproject.org. Emily Project. Emily Project – Objective. 2014 (http://www.theemilyproject.org/objective.htm). Accessed 26 January 2017.Google Scholar
44. Kelly, TR, et al. One health proof of concept: bringing a transdisciplinary approach to surveillance for zoonotic viruses at the human-wild animal interface. Preventive Veterinary Medicine 2017; 137: 112118. doi:10.1016/j.prevetmed.2016.11.023.Google Scholar
45. Nuotio, L, et al. Eradication of enzootic bovine leukosis from Finland. Preventive Veterinary Medicine 2003; 59: 4349.Google Scholar
Figure 0

Fig. 1. Representative agarose gel (1·5%) of field samples. (a) Multiplex PCR. (b) Nested PCR. Lane 1 – 100 bp ladder (Invitrogen); lane 2 – positive control; lane 3 – negative control; lane 4–8: beef samples; lane 9–13: milk samples.